| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |